Compounds > angiotensin ii
Page last updated: 2024-08-22

angiotensin ii and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

angiotensin ii has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bui, AD; Guru, PK; Helgeson, SA; Sanghavi, DK1

Other Studies

1 other study(ies) available for angiotensin ii and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia.
    BMJ case reports, 2020, Jun-28, Volume: 13, Issue:6

    Topics: Aged; Angiotensin II; Antineoplastic Agents; Humans; Lung; Male; Neutropenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Radiography, Thoracic; Shock, Septic; Vasoconstrictor Agents

2020